18^th Euro Obesity and Endocrinology Congress

Marjo-Riitta Järvelin, MD, MSc, PhD, FFPM, is Professor and Chair in Lifecourse Epidemiology at Imperial College London (IC), UK, also holding a visiting professorship at Brunel University London, UK and a part-time professorship at the University of Oulu, Finland. She has been running large-scale population-based studies for over 25 years, working on the genetic and early life environmental origins of multi-factorial diseases and disorders. She is a Scientific Director of the Northern Finland Birth Cohort (NFBC) research program and has an active role in research training as Director of Postgraduate Studies at School of Public Health, IC. Professor Järvelin has published over 700 original papers. She has been nominated on several prestigious visiting and collaboration awards, has received an award of Excellence in Genetic Epidemiology at Imperial College London, been honoured by the title, Epidemiologist of the Year in Finland and invited to join the Finnish Academy of Sciences.

Challenging life course approaches and their implications: New research concepts

Mircea Onofriescu is a Professor at the University of Medicine and Pharmacy "Gr.T. Popa", Iasi and Head of Department Obstetrics and Gynecology, Hospital “Cuza-Vodă”, Iasi. He has an MD, PhD in Obstetrics and Gynecology, Gestational Diabetes and Maternal-Fetal Influences. Ability in Materno-Fetal Medicine, Ultrasonography in Obstetrics and Gynecology, Hysteroscopy, Laparoscopy in Gynecology, In Vitro Fertilization. He is the President of the Romanian Society Obstetrics and Gynecology and the Romanian Society Reproductive Medicine. He is a Member of 10 international scientific associations and 12 Romanian scientific associations. He has experience in clinical trials, which include two international studies and six national grants. He has published 15 books as an Author and Co-Author.

Obesity in obstetrics

Mohamed Eddouks is Professor at Moulay Ismail University, Faculty of Sciences and Techniques Errachidia, Morocco. He is a researcher in Physiology and Pharmacology with a Master Degree in Metabolic and Molecular Endocrinology from University of Paris vi, a specialized certificate in Endocrine Pharmacology from University of Paris vii and PhD degrees in Physiology and Pharmacology from University of Liege, Belgium and Sidi Mohammed Ben Abdellah University, Fez, Morocco. After his post-doctoral fellowship at Department of Physiology, Faculty of Medicine of Montreal, Canada, he is working for the last 16 years on medicinal plants. His work on antidiabetic and antihypertensive plants is well recognized globally. His research focuses on ethnobiological as well as pharmacological issues in the use of Moroccan medicinal plants for the treatment of diabetes mellitus, obesity and hypertension. His contribution to this field includes four international books and more than 80 peer-reviewed articles and book chapters of international repute. He is Guest Editor of American Journal of Pharmacology and Toxicology, Lead Guest Editor of an annual special issue published by Evidence-Based and Complementary Alternative Medicine, Regional Editor of the Following journals: American Journal of Food Technology, Journal of Applied Sciences, Trends in Applied Sciences Research and Singapore Journal of Scientific research, Member of Editorial Board of several international journals. He has been honored with the first Prize of Scientific Research in 2008 by the Moroccan Association of Research and Development and the first Prize of the Federation of Arab Scientific Councils in 2016. He has been the Dean of Polydisciplinary Faculty of Errachidia from 2008 to 2012.

His research focuses on ethnobiological as well as pharmacological issues in the use of Moroccan medicinal plants for the treatment of diabetes mellitus, obesity and hypertension.

Sanjay Chatterjee has completed his MBBS (1979), MD (1983), Dip.BMSc, Certificate on Diabetology Care from Newcastle University, Australia

Metabolic Syndrome & Insulin Resistance. Cardiovascular complications Clinical Research in Diabetology Good Clinical Practice Certification for clinical trials – 2015 (last) Principal Investigator of several Multi-center, International Trials

Muhammad A Jawad is a board certifi ed through the American Board of Surgery and serves as the Medical Director of Orlando Regional Medical Center’s Bariatric Program. He has been an expert in Laparoscopic Surgery since 1989, where he has been performing complicated biliary, colon and endocrine surgery. He has performed more than 4,000 laparoscopic bariatric surgical cases since 2000, safely and with great success. He specializes in the laparoscopic gastric bypass, the adjustable Lap- Band, and sleeve gastrectomy procedures. He has presented more than 45 presentations both nationally and internationally on laparoscopic and bariatric surgery.

Laparoscopic and Bariatric Surgery.

Damien Byas is serving as an Associate Faculty member in a Master of Public Health (MPH) Program. He is currently working as a senior research fellow for the Centre for Organizational Research in Chicago, IL. He is currently serving as an Associate Faculty Member in a Master of Public Health (MPH) Program. He is the president of the North American Scientific Committee on Cardiovascular Health, a part-time Public Health Researcher, Senior Research Fellow, and an adjunct Professor for an MPH program. He has done his PhD in University of New Mexico and he is expertise in Global Health Research Epidemiology Biostatistics Quantitative Research.

Global Health Research Epidemiology Biostatistics Quantitative Research.

Shougang Wei serves as Professor, PhD supervisor and Deputy Director in Department of Children’s and Women’s Health, School of Public Health, Capital Medical University, Peking, China. He has been engaged in the study of child and adolescent health, mainly focused on the field of childhood obesity about its health risks, pathogenic factors, and preventive and treatment measures.

Childhood obesity about its health risks, pathogenic factors, and preventive and treatment measures.

Maria Fernanda Cury-Boaventura has completed his PhD on Human Physiology at the age of 26 years from University of São Paulo and postdoctoral studies from University of São Paulo. She is professor and researcher at Institute of Physical Activity and Sport Sciences since 2007. She has published more than 40 papers in reputed journals and has been serving as an editorial board member of repute. Medical School (HMS). At MGH, she is also affiliated faculty at the Mongan Institute of Health Policy and an Associate at the Disparities Solution Center. She is a Diplomate of the American Board of Obesity Medicine and a Fellow of the Obesity Society. Dr. Stanford received her BS and MPH from Emory University, her MD from the Medical College of Georgia School of Medicine, and her MPA from the Harvard Kennedy School of Government.

Obesity & associated health problems, Health Policy, cardiovascular risk factors.

Quang Kim Tran received an MD from the University of Medicine and Pharmacy at Ho Chi Minh City, Vietnam and a PhD in Vascular Biology and Clinical Cardiology Fellowship from Hamamatsu University School of Medicine, Japan. He pursued Post-doctoral Training in the School of Biological Sciences, University of Missouri–Kansas City, USA, where he later became a Research Instructor. He is now an Associate Professor in the Department of Physiology and Pharmacology, Des Moines University College of Osteopathic Medicine, Iowa, USA. He has served as President of the Iowa Chapter of the American Physiological Society and as Reviewer for various scientific journals in the cardiovascular field. involves understanding causes for type 2 diabetes and potential therapeutic targets. The main aim of the team is to develop translational multidisciplinary medical research into obesity and type 2 diabetes. The current research programmes are exploring the underlying mechanisms that lead to the pathogenesis of obesity mediated type 2 diabetes. As such we have researchers within the team focussed on human metabolism examining several aspects such as: the importance of adipokines on human adipocyte signalling, mediators and mechanisms of inflammation, understanding the importance of diet and cell signalling in response to metabolic endotoxinaemia, the role of ectopic fat in the liver and heart, as well as using mathematical modelling of human adipocyte systems.

Novel mechanistic insights into the actions of the G-protein coupled estrogen receptor as a moderator of cardiovascular health.A mechanistic model for the role of GPER as a moderator of cardiovascular functions will be presented. The data and summative model encourage therapeutic exploitation of GPER activation and expression in the management of cardiovascular morbidity.

Maarten Bak is a psychatrist since 1999, trained Maastricht Univesity Hospital. He has compledted his PhD in 2004: ‘Coping with psychosis; Blueler’s right’. He is director of the Medication monitor, assessing effects and side effects of long term antipsychotc use. The side effects monitored are metabolic effects, movement disorders and sexual side effects. His scienticfic wordk centers around effect and metabolic side effects of antipsychotics. He has published over 50 papers in reputed journals.

He is director of the Medication monitor, assessing effects and side effects of long term antipsychotc use. The side effects monitored are metabolic effects, movement disorders and sexual side effects. His scienticfic wordk centers around effect and metabolic side effects of antipsychotics. He has published over 50 papers in reputed journals

I trained in medicine at Cambridge and Birmingham and then worked for the Medical Research Council at their mineral metabolism unit in Leeds where I developed my interest in metabolic bone disease. I completed my training in endocrinology at Newcastle and moved to Manchester in 1990. My main academic interests are the effect of non-skeletal diseases on bone and the assessment and treatment of osteoporosis. I am at Tustee of the National Osteoporosis Society having previously been their Treasurer and secretary of the Bone and Tooth Society. I am a member of the NICE guidelines development group for osteoporosis.

I also have an interest in Paget's disease and am currently chairman of the National Association for the Relief of Paget's disease and an international adviser to the Paget Foundation in the United States

Don Schalch completed his M.D. at the Univ. of Cincinnati, OH, in 1960 and medicine residency and fellowship in endocrinology and metabolism at the Univ. of Rochester, NY, in 1964, whereupon he joined the faculty. He was visiting scientist at Erasmus Univ. in Rotterdam and at Kantonspital in Zürich in 1972-73, and joined the Univ. of Colorado Medical School facutly in Denver, CO in 1974. In 1982, he became chief of endocrinology at the Univ. of Wisconsin School of Medicine and Public Health. He has published 101 papers, been reviewer for 3 journals, and became emeritus professor in 1999.

Obesity: Associated Health Problems

Thais Borges Cesar is an Associate Professor of Nutrition, Faculty of Pharmaceutical Sciences, Sao Paulo State University (UNESP), Araraquara, Brazil. She has a BS in Biology and Ph.D. in Food Science and Nutrition, University of Sao Paulo, Brazil. She did post-doctoral at the Boston Universit and at the Citrus and Subtropical Products Research Laboratory, ARS-USDA. Dr Cesar’s scientific focus is investigating the nutritional and metabolic properties of citrus fruits in clinical studies and animal models, regarding to the effect of its bioactive compounds as a protection factor against the development of chronic diseases.

. Dr Cesar’s scientific focus is investigating the nutritional and metabolic properties of citrus fruits in clinical studies and animal models, regarding to the effect of its bioactive compounds as a protection factor against the development of chronic diseases.